Possible role of β-galactosidase in rheumatoid arthritis

References

• Arnold JN, Wormald MR, Sim RB, Rudd PM, Dwek RA. The impact of glycosylation on the biological function and structure of human immunoglobulins. Annu Rev Immunol. 2007;25(1):21–50.
   PubMed Web of Science ®Google Scholar
• Krapp S, Mimura Y, Jefferis R, Huber R, Sondermann P. Structural analysis of human IgG-Fc glycoforms reveals a correlation between glycosylation and structural integrity. J Mol Biol. 2003;325(5):979–89.
   PubMed Web of Science ®Google Scholar
• van Gaalen F, Ioan-Facsinay A, Huizinga TWJ, Toes R. The devil in the details: the emerging role of anticitrulline autoimmunity in rheumatoid arthritis. J Immunol. 2005;175(9):5575–80.
   PubMed Web of Science ®Google Scholar
• Parekh RB, Dwek RA, Rademacher TW. Rheumatoid-arthritis as a glycosylation disorder. Brit J Rheumatol. 1988;27:162–9.
   PubMedGoogle Scholar
• Parekh RB, Dwek RA, Sutton BJ, Fernandes DL, Leung A, Stanworth D. Association of rheumatoid-arthritis and primary osteo-arthritis with changes in the glycosylation pattern of total serum IgG. Nature. 1985;316(6027):452–7.
   PubMed Web of Science ®Google Scholar
• Rademacher TW, Williams P, Dwek RA. Agalactosyl glycoforms of IgG autoantibodies are pathogenic. Proc Natl Acad Sci USA. 1994;91(13):6123–7.
   PubMed Web of Science ®Google Scholar
• Rudd PM, Elliott T, Cresswell P, Wilson IA, Dwek RA. Glycosylation and the immune system. Science. 2001;291(5512):2370–6.
   PubMed Web of Science ®Google Scholar
• Ercan A, Cui J, Chatterton DEW, Deane KD, Hazen MM, Brintnell W, et al. Aberrant igg galactosylation precedes disease onset, correlates with disease activity, and is prevalent in autoantibodies in rheumatoid arthritis. Arthritis Rheum. 2010;62(8):2239–48.
   PubMed Web of Science ®Google Scholar
• Axford JS, Lydyard PM, Isenberg DA, Mackenzie L, Hay FC, Roitt IM, et al. Rheumatoid-arthritis. Lancet. 1987;2(8574):1486–8.
   PubMed Web of Science ®Google Scholar
• Wang YH, Xu DW, Tao R, Wang HR, Wang QH, Shen AG. Beta 1,4-Galactosyltransferase-I contributes to the inflammatory processes in synovial tissue of patients with rheumatoid arthritis. Inflamm Res. 2010;59(12):1009–18.
   PubMed Web of Science ®Google Scholar
• Krishna DR, Sperker B, Fritz P, Klotz U. Does pH 6 beta-galactosidase activity indicate cell senescence? Mech Ageing Dev. 1999;109(2):113–23.
   PubMed Web of Science ®Google Scholar
• Shipkowski S, Brenchley JE. Characterization of an unusual cold-active beta-glucosidase belonging to family 3 of the glycoside hydrolases from the psychrophilic isolate Paenibacillus sp strain C7. Appl Environ Microb. 2005;71(8):4225–32.
   PubMed Web of Science ®Google Scholar
• Tanaka H, Meisler M, Suzuki K. Activity of human hepatic beta-galactosidase toward natural glycosphingolipid substrates. Biochim Biophys Acta. 1975;398(3):452–63.
   PubMedGoogle Scholar
• Brunner N, Thompson EW, Spangthomsen M, Rygaard J, Dano K, Zwiebel JA. Lacz transduced human breast-cancer xenografts as an in vivo model for the study of invasion and metastasis. Eur J Cancer. 1992;28A(12):1989–95.
   PubMed Web of Science ®Google Scholar
• Buller CJ, Zang XP, Brackett DJ, Howard EW, Pento JT. Influence of KGF on breast cancer metastasis in nude mouse xenografts. Breast Cancer Res Treat. 2003;82:S92–S.
   Web of Science ®Google Scholar
• Dimri GP, Lee XH, Basile G, Acosta M, Scott C, Roskelley C, et al. A biomarker that identifies senescent human cells in culture and in aging skin in vivo. Proc Natl Acad Sci USA. 1995;92(20):9363–7.
   PubMed Web of Science ®Google Scholar
• Chatterjee SK, Bhattacharya M, Barlow JJ. Glycosyltransferase and glycosidase activities in ovarian-cancer patients. Cancer Res. 1979;39(6):1943–51.
   PubMed Web of Science ®Google Scholar
• Wielgat P, Walczuk U, Szajda S, Bień M, Zimnoch L, Mariak Z, et al. Activity of lysosomal exoglycosidases in human gliomas. J Neurooncol. 2006;80(3):243–9.
   PubMed Web of Science ®Google Scholar
• Olszewska E, Borzym-Kluczyk M, Rzewnicki I, Wojtowicz J, Rogowski M, Pietruski JK, et al. Possible role of alpha-mannosidase and beta-galactosidase in larynx cancer. Contemp Oncol (Pozn). 2012;16(2):154–8.
   PubMed Web of Science ®Google Scholar
• Asanuma D, Sakabe M, Kamiya M, Yamamoto K, Hiratake J, Ogawa M, et al. Sensitive beta-galactosidase-targeting fluorescence probe for visualizing small peritoneal metastatic tumours in vivo. Nat Commun. 2015;6;6463.
   PubMed Web of Science ®Google Scholar
• Han XL, Gross RW. Global analyses of cellular lipidomes directly from crude extracts of biological samples by ESI mass spectrometry: a bridge to lipidomics. J Lipid Res. 2003;44(6):1071–9.
   PubMed Web of Science ®Google Scholar
• Schwudke D, Oegema J, Burton L, Entchev E, Hannich JT, Ejsing CS, et al. Lipid profiling by multiple precursor and neutral loss scanning driven by the data-dependent acquisition. Anal Chem. 2006;78(2):585–95.
   PubMed Web of Science ®Google Scholar
• Porath J. Salting-out adsorption techniques for protein-purification. Biopolymers. 1987;26(S0):S193–S204.
   PubMedGoogle Scholar
• Ju LL, Wang YP, Xie Q, Xu XK, Li Y, Chen ZJ, et al. Elevated level of serum glycoprotein bifucosylation and prognostic value in Chinese breast cancer. Glycobiology. 2016;26(5):460–71.
   PubMed Web of Science ®Google Scholar
• Ciucanu I, Costello CE. Elimination of oxidative degradation during the per-O-methylation of carbohydrates. J Am Chem Soc. 2003;125(52):16213–9.
   PubMed Web of Science ®Google Scholar
• Anquetil F, Clavel C, Offer G, Serre G, Sebbag M. IgM and IgA rheumatoid factors purified from rheumatoid arthritis sera boost the Fc receptor- and complement-dependent effector functions of the disease-specific anti-citrullinated protein autoantibodies. J Immunol. 2015;194(8):3664.
   PubMed Web of Science ®Google Scholar
• Clavel C, Ceccato L, Anquetil F, Serre G, Sebbag M. Among human macrophages polarised to different phenotypes, the M-CSF-oriented cells present the highest pro-inflammatory response to the rheumatoid arthritis-specific immune complexes containing ACPA. Ann Rheum Dis. 2016;75(12):2184–91.
   PubMed Web of Science ®Google Scholar
• Clavel C, Nogueira L, Laurent L, Iobagiu C, Vincent C, Sebbag M, et al. Induction of macrophage secretion of tumor necrosis factor alpha through Fcgamma receptor IIa engagement by rheumatoid arthritis-specific autoantibodies to citrullinated proteins complexed with fibrinogen. Arthritis Rheum. 2008;58(3):678–88.
   PubMed Web of Science ®Google Scholar
• Laurent L, Clavel C, Lemaire O, Anquetil F, Cornillet M, Zabraniecki L, et al. Fcγ receptor profile of monocytes and macrophages from rheumatoid arthritis patients and their response to immune complexes formed with autoantibodies to citrullinated proteins. Ann Rheum Dis. 2011;70(6):1052–9.
   PubMed Web of Science ®Google Scholar
• Miyoshi E, Shinzaki S, Fujii H, Iijima H, Kamada Y, Takehara T. Role of aberrant IgG glycosylation in the pathogenesis of inflammatory bowel disease. Proteomics Clin Appl. 2016;10(4):384–90.
   PubMed Web of Science ®Google Scholar
• Odendahl M, Keitzer R, Wahn U, Hiepe F, Radbruch A, Dorner T, et al. Perturbations of peripheral B lymphocyte homoeostasis in children with systemic lupus erythematosus. Ann Rheum Dis. 2003;62(9):851–8.
   PubMed Web of Science ®Google Scholar
• Hansen A, Odendahl M, Reiter K, Jacobi AM, Feist E, Scholze J, et al. Diminished peripheral blood memory B cells and accumulation of memory B cells in the salivary glands of patients with Sjogren’s syndrome. Arthritis Rheum. 2002;46(8):2160–71.
   PubMed Web of Science ®Google Scholar
• Souto-Carneiro MM, Mahadevan V, Takada K, Fritsch-Stork R, Nanki T, Brown M, et al. Alterations in peripheral blood memory B cells in patients with active rheumatoid arthritis are dependent on the action of tumour necrosis factor. Arthritis Res Ther. 2009;11(3):R84.
   PubMed Web of Science ®Google Scholar
• Edwards JCW, Szczepański L, Szechiński J, Filipowicz-Sosnowska A, Emery P, Close DR, et al. Efficacy of B-cell-targeted therapy with rituximab in patients with rheumatoid arthritis. N Engl J Med. 2004;350(25):2572–81.
   PubMed Web of Science ®Google Scholar
• Yamamoto A, Adachi S, Kawamura S, Takahashi M, Kitani T, Ohtori T, et al. Localized beta-galactosidase deficiency – occurrence in cerebellar ataxia with myoclonus epilepsy and macular cherry-red spot – new variant of Gm1-gangliosidosis. Arch Intern Med. 1974;134(4):627–34.
   PubMedGoogle Scholar
• Alvarez AM, Ibanez M, Rotger R. Beta-galactosidase activity in bacteria measured by flow-cytometry. Biotechniques. 1993;15(6):974–6.
   PubMed Web of Science ®Google Scholar
• Ahmed AA, Giddens J, Pincetic A, Lomino JV, Ravetch JV, Wang LX, et al. Structural characterization of anti-inflammatory immunoglobulin G Fc proteins. J Mol Biol. 2014;426(18):3166–79.
   PubMed Web of Science ®Google Scholar
• Kurogochi M, Mori M, Osumi K, Tojino M, Sugawara S, Takashima S, et al. Glycoengineered monoclonal antibodies with homogeneous glycan (M3, G0, G2, and A2) using a chemoenzymatic approach have different affinities for Fc gamma RIIIa and variable antibody-dependent cellular cytotoxicity activities. PLoS One. 2015;10(7):e0132848.
   PubMed Web of Science ®Google Scholar
• Anthony RM, Nimmerjahn F, Ashline DJ, Reinhold VN, Paulson JC, Ravetch JV. Recapitulation of IVIG anti-inflammatory activity with a recombinant IgG Fc. Science. 2008;320(5874):373–6.
   PubMed Web of Science ®Google Scholar
• Pagan JD, Kitaoka M, Anthony RM. Engineered sialylation of pathogenic antibodies in vivo attenuates autoimmune disease. Cell. 2018;172(3):564–577.e13.
   PubMed Web of Science ®Google Scholar
• Jones MB, Nasirikenari M, Lugade AA, Thanavala Y, Lau J. Anti-inflammatory IgG production requires functional P1 promoter in β-galactoside α2,6-sialyltransferase 1 (ST6Gal-1) gene. J Biol Chem. 2012;287(19):15365–70.
   PubMed Web of Science ®Google Scholar
• Lee MM, Nasirikenari M, Manhardt CT, Ashline DJ, Hanneman AJ, Reinhold VN, et al. Platelets support extracellular sialylation by supplying the sugar donor substrate. J Biol Chem. 2014;289(13):8742–8.
   PubMed Web of Science ®Google Scholar
• Wang TT, Maamary J, Tan GS, Bournazos S, Davis CW, Krammer F, et al. Anti-HA glycoforms drive B cell affinity selection and determine influenza vaccine efficacy. Cell. 2015;162(1):160–9.
   PubMed Web of Science ®Google Scholar
• Jones MB, Oswald DM, Joshi S, Whiteheart SW, Orlando R, Cobb BA. B-cell-independent sialylation of IgG. Proc Natl Acad Sci USA. 2016;113(26):7207–12.
   PubMed Web of Science ®Google Scholar
• Ohmi Y, Ise W, Harazono A, Takakura D, Fukuyama H, Baba Y, et al. Sialylation converts arthritogenic IgG into inhibitors of collagen-induced arthritis. Nat Commun. 2016;7:11205.
   PubMed Web of Science ®Google Scholar
• Pfeifle R, Rothe T, Ipseiz N, Scherer HU, Culemann S, Harre U, et al. Regulation of autoantibody activity by the IL-23-TH17 axis determines the onset of autoimmune disease. Nat Immunol. 2017;18(1):104–13.
   PubMed Web of Science ®Google Scholar
• Cho YG, Cho ML, Min SY, Kim HY. Type II collagen autoimmunity in a mouse model of human rheumatoid arthritis. Autoimmun Rev. 2007;7(1):65–70.
   PubMed Web of Science ®Google Scholar
• Freitas EC, Alabarse PVG, Lora PS, Souza JM, Santo RCE, Almeida AS, et al. Collagen-induced arthritis in mice as a model of rheumatoid cachexia. Ann Rheum Dis. 2015;74(2):929–30.
   Google Scholar
• Ercan A, Cui J, Hazen MM, Batliwalla F, Royle L, Rudd PM, et al. Hypogalactosylation of serum N-glycans fails to predict clinical response to methotrexate and TNF inhibition in rheumatoid arthritis. Arthritis Res Ther. 2012;14(2):R43.
   PubMed Web of Science ®Google Scholar
• Gindzienska-Sieskiewicz E, Klimiuk PA, Kisiel DG, Gindzienski A, Sierakowski S. The changes in monosaccharide composition of immunoglobulin G in the course of rheumatoid arthritis. Clin Rheumatol. 2007;26(5):685–90.
   PubMed Web of Science ®Google Scholar
• Troelsen LN, Jacobsen S, Abrahams JL, Royle L, Rudd PM, Narvestad E, et al. IgG glycosylation changes and MBL2 polymorphisms: associations with markers of systemic inflammation and joint destruction in rheumatoid arthritis. J Rheumatol. 2012;39(3):463–9.
   PubMed Web of Science ®Google Scholar
• Houssiau FA, Devogelaer JP, Damme JV, Deuxchaisnes CND, Snick JV. Interleukin-6 in synovial-fluid and serum of patients with rheumatoid-arthritis and other inflammatory arthritides. Arthritis Rheum. 1988;31(6):784–8.
   PubMedGoogle Scholar
• Madhok R, Crilly A, Watson J, Capell HA. Serum interleukin-6 levels in rheumatoid-arthritis- correlations with clinical and laboratory indexes of disease-activity. Ann Rheum Dis. 1993;52(3):232–4.
   PubMed Web of Science ®Google Scholar
• Dienz O, Eaton SM, Bond JP, Neveu W, Moquin D, Noubade R, et al. The induction of antibody production by IL-6 is indirectly mediated by IL-21 produced by CD4+ T cells. J Exp Med. 2009;206(1):69–78.
   PubMed Web of Science ®Google Scholar
• Jego G, Bataille R, Pellat-Deceunynck C. Interleukin-6 is a growth factor for nonmalignant human plasmablasts. Blood. 2001;97(6):1817–22.
   PubMed Web of Science ®Google Scholar
• Choy EHS, Isenberg DA, Garrood T, Farrow S, Ioannou Y, Bird H, et al. Therapeutic benefit of blocking interleukin-6 activity with an anti-interleukin-6 receptor monoclonal antibody in rheumatoid arthritis – a randomized, double-blind, placebo-controlled, dose-escalation trial. Arthritis Rheum. 2002;46(12):3143–50.
   PubMed Web of Science ®Google Scholar
• Bochan MR, Brahmi Z. Target cell-directed rapid degradation of Tnf-alpha messenger RNA in human cytotoxic T cells. Immunol Lett. 1994;40(1):37–42.
   PubMed Web of Science ®Google Scholar
• Butler DM, Maini RN, Feldmann M, Brennan FM. Modulation of proinflammatory cytokine release in rheumatoid synovial membrane cell cultures. Comparison of monoclonal anti TNF-alpha antibody with the interleukin-1 receptor antagonist. Eur Cytokine Netw. 1995;6(4):225–30.
   PubMed Web of Science ®Google Scholar
• Lingampalli N, Sokolove J, Lahey LJ, Edison JD, Gilliland WR, Holers VM, et al. Combination of anti-citrullinated protein antibodies and rheumatoid factor is associated with increased systemic inflammatory mediators and more updates rapid progression from preclinical to clinical rheumatoid arthritis. Clin Immunol. 2018;195:119–26.
   PubMed Web of Science ®Google Scholar